Enliven Therapeutics
ELVN
#3821
Rank
ยฃ2.61 B
Marketcap
ยฃ35.55
Share price
-1.62%
Change (1 day)
114.92%
Change (1 year)

Earnings for Enliven Therapeutics (ELVN)

Earnings in 2026 (TTM): -ยฃ93.22 Million

According to Enliven Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ90.8 Million a decrease over its 2024 earnings that were of -ยฃ79.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enliven Therapeutics from 2022 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ93.22 Million2.67%
2025 -ยฃ90.8 Million14.45%
2024 -ยฃ79.34 Million25.17%
2023 -ยฃ63.38 Million115.33%
2022 -ยฃ29.44 Million